BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17445178)

  • 1. Modelling KIR-HLA genotype disparities in type 1 diabetes.
    van der Slik AR; Alizadeh BZ; Koeleman BP; Roep BO; Giphart MJ
    Tissue Antigens; 2007 Apr; 69 Suppl 1():101-5. PubMed ID: 17445178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.
    Shastry A; Sedimbi SK; Rajalingam R; Rumba I; Kanungo A; Sanjeevi CB
    Ann N Y Acad Sci; 2008 Dec; 1150():133-8. PubMed ID: 19120281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes.
    Mogami S; Hasegawa G; Nakayama I; Asano M; Hosoda H; Kadono M; Fukui M; Kitagawa Y; Nakano K; Ohta M; Obayashi H; Yoshikawa T; Nakamura N
    Tissue Antigens; 2007 Dec; 70(6):506-10. PubMed ID: 17990989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus.
    Santin I; de Nanclares GP; Calvo B; Gaafar A; Castaño L; ; Bilbao JR
    Hum Immunol; 2006; 67(1-2):118-24. PubMed ID: 16698433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response.
    Parham P
    Immunol Lett; 2004 Mar; 92(1-2):11-3. PubMed ID: 15081521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma.
    Pellett F; Siannis F; Vukin I; Lee P; Urowitz MB; Gladman DD
    Tissue Antigens; 2007 Apr; 69 Suppl 1():106-8. PubMed ID: 17445179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.
    Miyashita R; Tsuchiya N; Yabe T; Kobayashi S; Hashimoto H; Ozaki S; Tokunaga K
    Arthritis Rheum; 2006 Mar; 54(3):992-7. PubMed ID: 16508981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer immunoglobulin-like receptors.
    Moretta L; Moretta A
    Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.
    Butsch Kovacic M; Martin M; Gao X; Fuksenko T; Chen CJ; Cheng YJ; Chen JY; Apple R; Hildesheim A; Carrington M
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2673-7. PubMed ID: 16284396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR2DS3 is associated with protection against acute myeloid leukemia.
    Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
    Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders.
    Chen C; Busson M; Rocha V; Appert ML; Lepage V; Dulphy N; Haas P; Socié G; Toubert A; Charron D; Loiseau P
    Bone Marrow Transplant; 2006 Sep; 38(6):437-44. PubMed ID: 16892071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls.
    Nikitina-Zake L; Rajalingham R; Rumba I; Sanjeevi CB
    Ann N Y Acad Sci; 2004 Dec; 1037():161-9. PubMed ID: 15699512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14th International HLA and Immunogenetics Workshop: report from the reproductive immunology component.
    Varla-Leftherioti M; Keramitsoglou T; Spyropoulou-Vlachou M; Papadimitropoulos M; Kontopoulou-Antonopoulou V; Tsekoura C; Sankarkumar U; Paparistidis N; Ghosh K; Pawar A; Vrani V; Daniilidis M; Parapanissiou E; Diler AS; Carin M; Stavropoulos-Giokas C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():297-303. PubMed ID: 17445221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion.
    Denis L; Sivula J; Gourraud PA; Kerdudou N; Chout R; Ricard C; Moisan JP; Gagne K; Partanen J; Bignon JD
    Tissue Antigens; 2005 Oct; 66(4):267-76. PubMed ID: 16185321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.
    Rajalingam R
    Iran J Immunol; 2007 Jun; 4(2):61-78. PubMed ID: 17652846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis.
    Kitawaki J; Xu B; Ishihara H; Fukui M; Hasegawa G; Nakamura N; Mizuno S; Ohta M; Obayashi H; Honjo H
    Am J Reprod Immunol; 2007 Dec; 58(6):481-6. PubMed ID: 17997746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.
    Dupont B; Hsu KC
    Curr Opin Immunol; 2004 Oct; 16(5):634-43. PubMed ID: 15342011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.
    van der Slik AR; Koeleman BP; Verduijn W; Bruining GJ; Roep BO; Giphart MJ
    Diabetes; 2003 Oct; 52(10):2639-42. PubMed ID: 14514651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.